Home LiteratureArticle Details
PMID: 11485921 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection.

The American journal of pathology ·Vol. 159 ·No. 2 ·2001-08-00 ·Pages 631-8

Tekkanat KK, Maassab H, Berlin AA, Lincoln PM, Evanoff HL, Kaplan MH, Lukacs NW

Abstract

Respiratory syncytial virus (RSV) is a respiratory pathogen that can cause significant morbidity in infants and young children. Interestingly, the majority of children who acquire a RSV infection do not exhibit severe symptoms. Development of a Th1 response has been associated with resolution of symptoms in viral infections and may explain mild RSV illness. The current study investigated the cytokine response observed in mild disease in C57BL/6 mice that had low airway resistance and mucus production with little pulmonary inflammation. RSV infection in these mice was accompanied by a fourfold increase in interleukin-12(IL-12). Treatment of RSV-infected mice with anti-IL-12 resulted in an increase in airway hyperreactivity, mucus production, and airway inflammation (eosinophilia). Since IL-12 activation is dependent on Stat-4-mediated intracellular signal transduction, similar experiments were performed in Stat-4 deficient mice and demonstrated similar results to those obtained from anti-IL-12 treated mice. Again, there was an increase in airway hyperreactivity and mucus production, and goblet cell hypertrophy. These studies support the importance of IL-12 in the immune response to RSV infection resulting in resolution of disease and protection from inappropriate inflammatory responses.

MeSH Terms
Animals Antibodies/pharmacology Bronchial Hyperreactivity/physiopathology Bronchoalveolar Lavage Fluid/cytology DNA-Binding Proteins/deficiency,genetics,physiology Eosinophils/physiology Inflammation/physiopathology Interleukin-12/immunology,physiology Interleukin-13/biosynthesis Lung/pathology,physiopathology Mice Mice, Inbred C57BL Mice, Inbred DBA Mice, Knockout Respiratory Syncytial Virus Infections/physiopathology STAT4 Transcription Factor Signal Transduction Time Factors Trans-Activators/deficiency,genetics,physiology
Chemicals
Antibodies DNA-Binding Proteins Interleukin-13 STAT4 Transcription Factor Stat4 protein, mouse Trans-Activators Interleukin-12
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Tekkanat K K
Department of Pediatrics, University of Michigan Medical School, 1301 Catherine, Ann Arbor, MI 48109-0602, USA.
Maassab H
Berlin A A
Lincoln P M
Evanoff H L
Kaplan M H
Lukacs N W
References (54)
54 references, click to expand
  1. Respiratory syncytial virus: A continuing culprit and conundrum.
    J Pediatr. 1999 Aug;135(2 Pt 2):2-7 PMID: 10431132
  2. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice.
    J Clin Invest. 1997 May 1;99(9):2183-91 PMID: 9151790
  3. Comparative effects of interleukin-12 and interleukin-4 on cytokine responses by antigen-stimulated memory CD4+ T cells of cattle: IL-12 enhances IFN-gamma production, whereas IL-4 has marginal effects on cytokine expression.
    J Interferon Cytokine Res. 1999 Jul;19(7):741-9 PMID: 10454344
  4. Initial and innate responses to viral infections--pattern setting in immunity or disease.
    Curr Opin Microbiol. 1999 Aug;2(4):374-81 PMID: 10458991
  5. Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection.
    Pediatrics. 1999 Sep;104(3 Pt 1):463-7 PMID: 10469770
  6. Decreased interleukin-12 levels in umbilical cord blood in children who developed acute bronchiolitis.
    Pediatr Pulmonol. 1999 Sep;28(3):175-80 PMID: 10495333
  7. Intranasal IFN-gamma gene transfer protects BALB/c mice against respiratory syncytial virus infection.
    Vaccine. 1999 Oct 14;18(5-6):558-67 PMID: 10519947
  8. Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model.
    Vaccine. 2000 Jan 31;18(14):1412-8 PMID: 10618539
  9. Influence of IL-12 on interferon-gamma production by bovine leucocyte subsets in response to bovine respiratory syncytial virus.
    Vet Immunol Immunopathol. 1998 May 15;63(1-2):69-72 PMID: 9656442
  10. Respiratory syncytial virus and human bronchial epithelium.
    Arch Otolaryngol Head Neck Surg. 1998 Jul;124(7):777-83 PMID: 9677113
  11. The regulation of IL-12: its role in infectious, autoimmune, and allergic diseases.
    J Allergy Clin Immunol. 1998 Jul;102(1):11-5 PMID: 9679841
  12. Interleukin-12: a cytokine at the interface of inflammation and immunity.
    Adv Immunol. 1998;70:83-243 PMID: 9755338
  13. Interleukin 12 deficiency associated with recurrent infections.
    Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13125-9 PMID: 9789052
  14. Requirement for IL-13 independently of IL-4 in experimental asthma.
    Science. 1998 Dec 18;282(5397):2261-3 PMID: 9856950
  15. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.
    J Clin Invest. 1999 Mar;103(6):779-88 PMID: 10079098
  16. Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation.
    Scand J Immunol. 1999 Mar;49(3):229-36 PMID: 10102639
  17. Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis.
    J Immunol. 1999 May 15;162(10):6071-9 PMID: 10229848
  18. Stem cell factor-induced airway hyperreactivity in allergic and normal mice.
    Am J Pathol. 1999 Apr;154(4):1259-65 PMID: 10233863
  19. Bovine interleukin-12 and modulation of IFNgamma production.
    Vet Immunol Immunopathol. 1999 May;68(2-4):193-207 PMID: 10438320
  20. Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent.
    J Virol. 1999 Aug;73(8):6590-7 PMID: 10400756
  21. The RSV-asthma link: the emerging story. Introduction.
    J Pediatr. 1999 Aug;135(2 Pt 2):1 PMID: 10431131
  22. Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis.
    J Infect Dis. 2000 May;181(5):1772-5 PMID: 10823782
  23. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions.
    J Immunol. 2000 Dec 15;165(12):7109-15 PMID: 11120841
  24. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent.
    J Immunol. 2001 Mar 1;166(5):3542-8 PMID: 11207314
  25. Highlights of the international symposium on immunotherapeutic prospects of infectious diseases.
    Nat Immun Cell Growth Regul. 1991;10(4):185-95 PMID: 1896053
  26. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    J Immunol. 1994 Feb 1;152(3):1253-64 PMID: 7905500
  27. The role of interleukin 12 in the immune response, disease and therapy.
    Immunol Today. 1994 Oct;15(10):460-3 PMID: 7945769
  28. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity.
    J Infect Dis. 1995 Sep;172(3):734-8 PMID: 7658066
  29. RSV and chronic asthma.
    Lancet. 1995 Sep 23;346(8978):789-90 PMID: 7674741
  30. Interleukin-12.
    Int Arch Allergy Immunol. 1995 Oct;108(2):103-12 PMID: 7549496
  31. Respiratory syncytial virus in infants and children.
    Nurse Pract. 1995 Sep;20(9):24-9 PMID: 7501313
  32. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections.
    J Immunol. 1996 Feb 1;156(3):1138-42 PMID: 8557990
  33. Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern.
    J Virol. 1996 May;70(5):2852-60 PMID: 8627759
  34. Does interleukin-12 play a role in the viral immune response?
    Ann N Y Acad Sci. 1996 Oct 31;795:366-7 PMID: 8958956
  35. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection.
    J Virol. 1997 Jan;71(1):678-85 PMID: 8985399
  36. Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma.
    J Immunol. 1997 Jun 1;158(11):5560-5 PMID: 9164981
  37. IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness.
    J Immunol. 1997 Jul 1;159(1):328-34 PMID: 9200470
  38. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.
    J Clin Invest. 1997 Jul 1;100(1):226-33 PMID: 9202075
  39. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response.
    Am J Respir Crit Care Med. 1997 Jul;156(1):190-5 PMID: 9230746
  40. T cell genetic background determines maintenance of IL-12 signaling: effects on BALB/c and B10.D2 T helper cell type 1 phenotype development.
    J Immunol. 1997 Aug 15;159(4):1767-74 PMID: 9257839
  41. IFN-gamma is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb.
    J Immunol. 1997 Oct 1;159(7):3444-52 PMID: 9317143
  42. Targeting IL-12, the key cytokine driving Th1-mediated autoimmune diseases.
    Chem Immunol. 1997;68:175-97 PMID: 9329222
  43. Interleukin-12 in infectious diseases.
    Clin Microbiol Rev. 1997 Oct;10(4):611-36 PMID: 9336665
  44. Biological properties and therapeutic applications of interleukin-12.
    Eur Cytokine Netw. 1997 Sep;8(3):305-7 PMID: 9346369
  45. Respiratory syncytial virus infection in infants and young children.
    J Fam Pract. 1997 Dec;45(6):473-81 PMID: 9420581
  46. Animal models of respiratory syncytial virus infection.
    Clin Infect Dis. 1997 Dec;25(6):1363-8 PMID: 9431379
  47. Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma.
    Pediatr Pulmonol Suppl. 1997;16:88-9 PMID: 9443219
  48. Respiratory syncytial virus affects pulmonary function in BALB/c mice.
    J Infect Dis. 1998 Feb;177(2):269-76 PMID: 9466511
  49. Local variability in respiratory syncytial virus disease severity.
    Arch Dis Child. 1997 Nov;77(5):410-4 PMID: 9487963
  50. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity.
    Eur J Immunol. 1998 Feb;28(2):413-23 PMID: 9521048
  51. Interleukin-12 as a target for modulation of the inflammatory response in asthma.
    Allergy. 1998 Feb;53(2):113-9 PMID: 9534908
  52. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.
    Annu Rev Immunol. 1998;16:495-521 PMID: 9597139
  53. Various immunological phenotypes are associated with increased airway responsiveness.
    Clin Exp Allergy. 1998 May;28(5):625-34 PMID: 9645600
  54. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models.
    J Immunol. 1999 Aug 15;163(4):2193-201 PMID: 10438961
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
2001-08-00
Pages
631-8
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1850534
Subset
IM
Grants
NHLBI NIH HHS · HL59178 · United States
NIAID NIH HHS · R01 AI036302 · United States
NHLBI NIH HHS · P01 HL031963 · United States
NIAID NIH HHS · AI36302 · United States
NHLBI NIH HHS · R01 HL059178 · United States
NHLBI NIH HHS · HL31963 · United States
NIAID NIH HHS · R29 AI036302 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com